Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- Angle completes enrolment in Parsortix breast cancer study
7 Mar 2019 - Angle Enrolls First Patients In Ovarian Cancer Study
28 Feb 2019 - Angle client demonstrates new use for 'Parsortix' system
25 Feb 2019 - Angle's 'Parsortix' used in new groundbreaking cancer research
11 Feb 2019 - Angle Reports Widened Interim Loss On Higher Operating Costs
31 Jan 2019 - UK Earnings, Trading Statements Calendar - Next 7 Days
24 Jan 2019 - Angle Shares Jump As Parsortix System Used In New Cancer Treatment
10 Jan 2019 - ANGLE To Acquire Remaining Stake In US Subsidiary For GBP467,500 (ALLISS)
5 Nov 2018
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
Angle completes enrolment in Parsortix breast cancer study
(Sharecast News) - Liquid biopsy company Angle announced on Thursday that enrolment for its 'Parsortix' FDA clinical study for metastatic breast cance...
Angle Enrolls First Patients In Ovarian Cancer Study
LONDON (Alliance News) - Angle PLC on Thursday said it has enrolled the first patients in an ovarian cancer verification study, after receiving ethics...
Angle client demonstrates new use for 'Parsortix' system
(Sharecast News) - Liquid biopsy company Angle said on Monday that one of its leading customers, the Disseminated Cancer Cell Network (DCCNet) in Dues...
Angle's 'Parsortix' used in new groundbreaking cancer research
(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 'Parsortix' system had been utilised in further "groundbreaking" cancer re...
Angle Reports Widened Interim Loss On Higher Operating Costs
LONDON (Alliance News) - Angle PLC on Thursday reported a widened interim loss on an increase operating costs.In the six months to October 31, the tum...
UK Earnings, Trading Statements Calendar - Next 7 Days
Friday 25 January BonmarcheTrading Statement AG BarrTrading GroupQ3 Smaller
Angle Shares Jump As Parsortix System Used In New Cancer Treatment
LONDON (Alliance News) - Angle PLC shares spiked late Thursday afternoon after the company said its Partsortix system will be used in "ground-breaking...
ANGLE To Acquire Remaining Stake In US Subsidiary For GBP467,500 (ALLISS)
LONDON (Alliance News) - Liquid biopsy company ANGLE PLC said on Monday it has agreed to acquire the remaining shares in US subsidiary ANGLE North Ame...
Follow the stocks
